Atlas Trials

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Clinical trial NCT01755624 · UNKNOWN

Trial details

NCT number
NCT01755624
Sponsor
NovoCure Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
1-5 Brain Metastases From Non-Small Cell Lung Cancer
Start date
2013-01-01
Primary completion
2017-07-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.